Outcome of heroin-dependent adolescents presenting for opiate substitution treatment

Journal of Substance Abuse Treatment

Volumn 42, Issue 1, 2012, Pages 35-44

  Smyth, Bobby P ^a   Fagan, John ^b   Kernan, Kathy ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Drug Treatment Centre Board   (Ireland)

Author keywords

Adolesence; Hepatitis C; Heroin dependence; HIV; Methadone; Mortality; Opiate substitution treatment

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE;

ADOLESCENT; ARTICLE; DETOXIFICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; HEALTH PROGRAM; HEPATITIS C; HEROIN DEPENDENCE; HEROIN DEPENDENCE; PLUS NALOXONE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPIATE SUBSTITUTION TREATMENT; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; BUPRENORPHINE; COHORT STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PRISONERS; RETROSPECTIVE STUDIES; SEX FACTORS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 82455203941     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.07.007     Document Type: Article

References (34)

1. Bell J., Mutch C. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review. Drug and Alcohol Review 2006, 25:167-171.
2. Bulter S. The making of the methadone protocol: The Irish system?. Drugs: Education, Prevention and Policy 2002, 9:311-324.
3. Carew A.M., Bellerose D., Lyons S., Long J. Trends in treated problem opiate use in Ireland, 2002 to 2007 2009, Health Research Board., Dublin.
4. Center for Substance Abuse Treatment Initial screening, admission procedures, and assessment techniques. Medication-assisted treatment for opioid addiction in opioid treatment programs 2005, 43-61. Substance Abuse and Mental Health Services Administration, Rockville (MD), Treatment improvement protocol (TIP) Series. DHHS Publication No. (SMA) 05-4048. S.L. Batki, J.F. Kauffman, I. Marion, M.W. Parrino, G.E. Woody (Eds.).
5. College of Physicians & Surgeons of Ontario Methadone maintenance guidelines 2005, College of Physicians & Surgeons of Ontario, Toronto, Ontario.
6. Comptroller and Auditor General Drug addiction treatment and rehabilitation. Dublin: Department of Community, Rural and Gaeltacht Affairs (accessed 7 December 2010). http://www.audgen.gov.ie/documents/vfmreports/64_Drug_Addiction_and_Rehab.pdf.
7. Crome I.B., Christian J., Green C. The development of a unique designated community drug service for adolescents: Policy prevention education implication. Drugs: Education, Prevention and Policy 2000, 7:87-108.
8. Department of Health Guidance for the pharmacological management of substance misuse among young people. London: Department of Health (accessed October 12, 2009). http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_106429.pdf.
9. Dept of Health & Children Report of the Working Group on treatment of under 18s presenting to treatment services with serious drug problems 2005, Dept of Health & Children, Dublin, Dublin.
10. Fishman M. Placement criteria and treatment planning for adolescents with substance use disorders. Clinical manual of adolescent substance abuse treatment 2011, American Psychiatric Publishing, Washington, DC. Y. Kaminer, K.C. Winters (Eds.).
11. Fudala P.J., Woody G.W. Recent advances in the treatment of opiate addiction. Current Psychiatry Reports 2004, 6:339-346.
12. Fugelstad A., Stenbacka M., Leifman A., Nylander M., Thiblin I. Methadone maintenance treatment: The balance between life-saving treatment and fatal poisonings. Addiction 2006, 102:406-412.
13. Gonzales R., Brecht M., Mooney L., Rawson R.A. Prescription and over-the-counter drug treatment admissions to the California public treatment system. Journal of Substance Abuse Treatment 2011, 40:224-229.
14. Hopfer C.J., Khuri E., Crowley T.J., Hooks S. Adolescent heroin use: A review of the descriptive and treatment literature. Journal of Substance Abuse Treatment 2002, 23:231-237.
15. Kaminer Y., Marsch L.A. Pharmacotherapy of adolescent substance use disorders. Clinical manual of adolescent substance abuse treatment 2011, American Psychiatric Publishing, Washington, DC. Y. Kaminer, K.C. Winters (Eds.).
16. Kellogg S., Melia D., Khuri E., Lin A., Ho A., Kreek M.J. Adolescent and young adult heroin patients: Drug use and success in methadone maintenance treatment. Journal of Addictive Disease 2006, 25:15-25.
17. Lehmann W.X. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. NIDA Monograph 1973, 8:82-83.
18. Marsch L. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction 1998, 93:515-532.
19. Marsch L.A., Bickel W.K., Badger G.J., Stothart M.E., Quesnel K.J., Stanger C., Brooklyn J. Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial. Archives of General Psychiatry 2005, 62:1157-1164.
20. Marsden J., Gossop M., Stewart D., Best D., Farrell M., Lehmann P., et al. The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome. Addiction 1998, 93:1857-1868.
21. Marsden J., Eastwood B., Bradbury C., Dale-Perera A., Farrell M., Hammond P., et al. Effectiveness of community treatments for heroin and crack cocaine addiction in England: A prospective, in-treatment cohort study. Lancet 2009, 374:1262-1270.
22. McKay J.R. Continuing care research: What we have learned and where we are going. Journal of Substance Abuse Treatment 2009, 36:131-145.
23. Millman R.B., Khuri E.T., Nyswander M.E. Therapeutic detoxification of adolescent heroin addicts. Annals of the New York Academy of Science 1978, 311:153-164.
24. Minozzi S., Amato L., Davoli M. Maintenance treatments for opiate dependent adolescent. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007210. 10.1002/14651858.CD007210.pub2.
25. Motamed M., Marsch L.A., Solhkhah R., Bickel W.K., Badger G.J. Differences in treatment outcomes between prescription opioid-dependent and heroin-dependent adolescents. Journal of Addiction Medicine 2008, 2:158-164.
26. NICE Methadone and buprenorphine for the management of opioid dependence 2007, National Institute for Health & Clinical Excellence., London.
27. NTA Getting to grips with substance misuse among young people. London: National Treatment Agency for Substance Misuse (accessed 24 June 2010). http://www.nta.nhs.uk/uploads/nta_young_peoples_report_2009.pdf.
28. O'Brien C.P. Adolescent opioid abuse. Archives of General Psychiatry 2005, 62:1165.
29. SAMHSA The TEDS Report: Characteristics of adolescent heroin admissions 2009, Substance Abuse & Mental Health Service., Rockville, MD.
30. Sells S.B., Simpson D.D. Evaluation of treatment outcome for youths in the Drug Abuse Reporting Program (DARP): A follow-up study. Youth drug abuse: Problems, issues and treatment 1979, 571-622. Lexington Books, Lanham, MD. G.M. Beschner, A.A. Friedman (Eds.).
31. Smyth B., O'Brien M. Children attending addiction treatment services in Dublin, 1990-1999. European Addiction Research 2004, 10:68-74.
32. Smyth B.P., O'Connor J.J., Barry J., Keenan E. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin. Journal of Epidemiology & Community Health 2003, 57:310-311.
33. Woody G.E., Poole S.A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P., et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. Journal of the American Medical Association 2008, 300:2003-2011.
34. van Beek I., Dwyer R., Dore G.J., Luo K., Kaldor J.M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. British Medical Journal 1998, 317:433-437.